Tag Archives: IPO

What Do The IP Lawyers Have To Say In The Myriad Remand?

Several associations and organizations of intellectual property lawyers submitted amicus briefs in the Federal Circuit remand of Association for Molecular Pathology v. Myriad Genetics, Inc. (the ACLU “gene patenting”/BRCA1 case). While many make the same arguments, there are some points that may stand out enough to get the court’s attention. (See this article for my … Continue reading this entry

IPOs, Acquisitions, "Bare-Knuckle Tactics" and More: A Recent Panel Discussion

On May 10th, at Foley & Lardner LLP's 2011 Boston Life Sciences conference, I participated on a panel entitled "Match Making: Identifying Partners, Creative Collaborations and Long Term Outcomes." Mike Morency, Ph.D., an Intellectual Property partner in Foley's Boston office moderated the discussion among John A. Delyani, Ph.D., M.B.A., Head, Therapeutic Areas for Strategic Alliances at the Novartis Institute of BioMedical Research, Gerry Brunk, Managing Director at Lumira Capital, and me. … Continue reading this entry

Join Me For The IP Chat Channel Reissue Webinar

On Thursday, June 2, 2011, I will be a speaker for an IPO IP Chat Channel webinar: PATENT REISSUE: THE IMPACT OF RECENT DECISIONS BY THE FEDERAL CIRCUIT As summarized in the IP Chat Channel announcement: Two recent decisions by the Federal Circuit regarding reissue proceedings offer help to patentholders, to different degrees. In re … Continue reading this entry